Colantonio, Lisandro D. http://orcid.org/0000-0001-8742-1788
Monda, Keri L.
Rosenson, Robert S.
Brown, Todd M.
Mues, Katherine E.
Howard, George
Safford, Monika M.
Yedigarova, Larisa
Farkouh, Michael E.
Muntner, Paul
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01 NS041588)
National Heart, Lung, and Blood Institute (R01 HL080477, K24 HL111154)
Article History
First Online: 11 February 2019
Compliance with Ethical Standards
:
: KLM, KEM, and LY are employed by Amgen, Inc. KLM and LY also are stockholders of Amgen, Inc. RSR, TMB, MMS, MEF, and PM receive research support from Amgen, Inc. RSR also receives research support from Akcea, Astra Zeneca, Medicines Company, Regeneron and Sanofi, serves on Advisory Boards for Akcea, Amgen, Inc., CVS Caremark, Easy Vitals, Regeneron and Sanofi, receives consulting fees and honoraria from Amgen, Regeneron, C5, CVS Caremark, Kowa and Pfizer, and receives royalties from UpToDate. TMB also receives research support from Astra Zeneca. PM also has received an honorarium from Amgen, Inc. LDC and GH have no disclosures.
: All procedures performed in the current student were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The REGARDS study protocol was approved by the Institutional Review Boards governing research in human subjects at the participating centers.
: Informed consent was obtained from all individual participants included in the REGARDS study.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.